The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release

No abstract is available for this paper.

• Publication year

  2016

• Venue

  British Journal of Pharmacology

• Publication date

  2016-03-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/bph.13424PMID 27027724PMCID PMC4940823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fmoc Solid Phase Peptide Synthesis: A Practical Approach (Practical Approach Series)

  2019influential reference
• The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release

  2016cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors

  2015cited by this paper
• Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

  2015cited by this paper
• Experimental design and analysis and their reporting: new guidance for publication in BJP

  2015cited by this paper
• What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?

  2014cited by this paper
• The influence of James and Darwin on Cajal and his research into the neuron theory and evolution of the nervous system

  2014cited by this paper
• Brain renin-angiotensin system and dopaminergic cell vulnerability

  2014cited by this paper
• Angiotensin‐Converting Enzyme Inhibitors and Alzheimer's Disease Progression in Older Adults: Results from the Réseau sur la Maladie d'Alzheimer Français Cohort

  2013cited by this paper
• The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.

  2013cited by this paper
• A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme

  2013influential reference
• A Role for the Brain RAS in Alzheimer’s and Parkinson’s Diseases

  2013cited by this paper
• Therapeutic approach for neuronal disease by regulating renin-angiotensin system.

  2013cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

  2013influential reference
• Target identification and mechanism of action in chemical biology and drug discovery.

  2013cited by this paper
• Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

  2012cited by this paper
• Angiotensin II AT1 Receptor Blockers Ameliorate Inflammatory Stress: A Beneficial Effect for the Treatment of Brain Disorders

  2012cited by this paper
• Dopamine release in the basal ganglia.

  2011cited by this paper
• Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a.

  2011cited by this paper
• Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats.

  2011cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• The role of the central renin-angiotensin system in Parkinson’s disease

  2010cited by this paper
• The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone

  2008cited by this paper
• Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats.

  2008influential reference
• Identification of novel peptide hormones in the human proteome by hidden Markov model screening.

  2007cited by this paper
• Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

  2007cited by this paper
• Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats

  2006cited by this paper
• The CNS renin-angiotensin system

  2006cited by this paper
• A continuous fluorescence resonance energy transfer angiotensin I-converting enzyme assay

  2006influential reference
• Regulation of ERK1/2 activity by ghrelin‐activated growth hormone secretagogue receptor 1A involves a PLC/PKCɛ pathway

  2006cited by this paper
• Bridging neuropeptidomics and genomics with bioinformatics: Prediction of mammalian neuropeptide prohormone processing.

  2006cited by this paper
• From the Genome to the Proteome: Uncovering Peptides in the Apis Brain

  2006cited by this paper
• Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway.

  2006cited by this paper
• Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap*S

  2005influential reference
• Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression

  2004cited by this paper
• The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory.

  2004cited by this paper
• Tissue renin angiotensin systems.

  2004cited by this paper
• Angiotensin as a target for the treatment of Alzheimer’s disease, anxiety and depression

  2004cited by this paper
• Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2.

  2003cited by this paper
• Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity*

  2001cited by this paper
• New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals

  2000cited by this paper
• Ghrelin is a growth-hormone-releasing acylated peptide from stomach

  1999influential reference
• Rat Hippocampal Neurons Are Critically Involved in Physiological Improvement of Memory Processes Induced by Cholecystokinin-B Receptor Stimulation

  1999influential reference
• Mapping tissue angiotensin‐converting enzyme and angiotensin AT1, AT2 and AT4 receptors

  1998cited by this paper
• CAPTOPRIL INHIBITS BOTH DOPAMINERGIC AND CHOLINERGIC NEUROTRANSMISSION IN THE CENTRAL NERVOUS SYSTEM

  1998cited by this paper
• The CCK‐B Agonist, BC264, Increases Dopamine in the Nucleus Accumbens and Facilitates Motivation and Attention After lntraperitoneal Injection in Rats

  1997cited by this paper
• Angiotensin‐Converting Enzyme Modulates Dopamine Turnover in the Striatum

  1997influential reference
• Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry

  1996cited by this paper
• The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens

  1995cited by this paper
• Intrastriatal angiotensin II induces turning behaviour in 6-hydroxydopamine lesioned rats.

  1995cited by this paper
• Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats.

  1993cited by this paper
• [The tissue renin-angiotensin systems].

  1993influential reference
• Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat

  1992influential reference
• Angiotensin-converting enzyme inhibition, angiotensin, and cognition.

  1992cited by this paper
• Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum

  1991cited by this paper
• Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes.

  1991influential reference
• The organization of the projection from the cerebral cortex to the striatum in the rat.

  1989influential reference
• A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.

  1988cited by this paper
• Autoradiographic visualization of angiotensin-converting enzyme in rat brain with [3H]captopril: localization to a striatonigral pathway.

  1984cited by this paper
• Stimulating effect of angiotensin II on the spontaneous release of newly synthetized [3H]dopamine in rat striatal slices.

  1979cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper
• System Journal of Renin-angiotensin-aldosterone Journal of Renin-angiotensin-aldosterone System the Role of the Central Renin-angiotensin System in Parkinson's Disease Journal of Renin-angiotensin-aldosterone System Additional Services and Information For

  year unknowncited by this paper

• ACE1-targeting peptide Acein ameliorates UV-induced skin damage and aging in vivo and in vitro via downregulation of the pro-aging factor CLEC4G.

  2025cites this paper
• The peptide Acein promotes dopamine secretion through clec-126 to extend the lifespan of elderly C. elegans

  2023cites this paper
• Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond

  2023cites this paper
• Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice

  2022cites this paper
• Urolithin C increases glucose‐induced ERK activation which contributes to insulin secretion

  2020cites this paper
• Transcriptional analysis of renal dopamine-mediated Na+ homeostasis response to environmental salinity stress in Scatophagus argus

  2019cites this paper
• Neuroprotective Effects of Sulphated Agaran from Marine Alga Gracilaria cornea in Rat 6‐Hydroxydopamine Parkinson's Disease Model: Behavioural, Neurochemical and Transcriptional Alterations

  2017cites this paper
• Joseph Rudinger memorial lecture: Unexpected functions of angiotensin converting enzyme, beyond its enzymatic activity

  2017cites this paper
• The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release

  2016cites this paper